REGENXBIO Inc.
RGNX
$6.34
$0.213.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -83.91% | 14.63% | 25.50% | 27.17% | 39.38% |
| Total Depreciation and Amortization | -2.96% | -3.70% | -4.59% | -6.46% | -7.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.02% | 31.93% | -8.95% | -17.61% | -29.91% |
| Change in Net Operating Assets | -120.38% | 112.90% | 714.33% | 1,259.92% | 184.84% |
| Cash from Operations | -178.17% | 28.40% | 43.32% | 54.02% | 56.44% |
| Capital Expenditure | 9.58% | 0.90% | -20.22% | 21.58% | 49.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -90.86% | -112.71% | -110.19% | -102.63% | -6.01% |
| Cash from Investing | -92.61% | -115.34% | -113.52% | -106.03% | -4.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 22.69% | -98.98% | -99.02% | -98.95% | -99.01% |
| Repurchase of Common Stock | -67.72% | 34.54% | 34.54% | 47.26% | 37.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 412.13% | 388.82% | 364.60% | 359.81% | 21.87% |
| Cash from Financing | 421.92% | 25.99% | 34.09% | 21.51% | -135.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -770.65% | -200.24% | -34.72% | 297.04% | -60.06% |